Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mylan | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Mylan

Merrill Lynch vet Cuneo named CFO at Mylan

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Andrew G. Cuneo has been named vice president of global business development at Mylan, Inc. Mr. Cuneo is responsible for coordinating Mylan’s global business development and strategic efforts in close alignment with the company’s executive leadership team.

He joins Mylan from Merrill Lynch, a financial management and advisory firm, where he worked for more than a decade on strategic advisory and capital markets transactions, primarily in the health care sector. Most recently he served as a director in its Global Healthcare Investment Banking group.

Mylan’s vice chairman and chief executive office Robert J. Coury remarked, “Drew brings a wealth of experience in the pharmaceutical, biotechnology and health care sectors. His familiarity with our industry – and in particular with Mylan given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”

“Mylan has emerged as one of the industry’s best run and most progressive pharmaceutical franchises,” said Mr. Cuneo. “I’m excited to be able to continue participating and to further contribute to the development and execution of its plans for profitable commercial expansion.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters